Pancreatic Cancer

• CLINICAL_TRIALS trial_result · 2025-04-27
  Clinical Trial Update: LIQUID BIOPSY FOCUSING ON CIRCULATING TUMOR CELLS AND CIRCULATING TUMOR DNA AS PRECISION MEDICINE IN GASTROINTESTINAL TUMORS

  A clinical trial update describes using liquid biopsies of circulating tumor cells and circulating tumor DNA to guide precision medicine in …

• CLINICAL_TRIALS trial_result · 2025-04-22
  Clinical Trial Update: A Clinical Study of CEA-targeted CAR-T in the Treatment of CEA-positive Advanced Malignant Solid Tumors [Phase 1]

  This clinical trial update reports the completion of a Phase 1 study of CEA-targeted CAR-T therapy for CEA-positive advanced solid tumors, i…

• CLINICAL_TRIALS trial_result · 2025-04-18
  Clinical Trial Update: Liposomal Irinotecan in Combination With Oxaliplatin, Leucovorin, and 5-fluorouracil for Patients With Locally Advanced Pancreatic Carcinoma: [Phase 2]

  A Phase 2 trial evaluated liposomal irinotecan in combination with oxaliplatin, leucovorin, and 5-fluorouracil in locally advanced pancreati…

• CLINICAL_TRIALS trial_result · 2025-04-18
  Clinical Trial Update: Study of an Anti-HER3 Antibody, HMBD-001, With or Without Chemotherapy in Patients With Solid Tumors Harboring an NRG1 Fusion or HER3 Mutation [Phase 1]

  Phase 1 clinical trial update of HMBD-001, an anti-HER3 antibody, evaluating its use with or without chemotherapy in solid tumors with NRG1 …

• CLINICAL_TRIALS trial_result · 2025-04-17
  Clinical Trial Update: 2nd-line Therapy With Nal-IRI After Gem/Nab-pac in Advanced Pancreatic Cancer - Predictive Role of 1st-line Therapy [Phase 3]

  A Phase 3 study evaluating second-line liposomal irinotecan (nal-IRI) after gemcitabine/nab-paclitaxel in locally advanced or metastatic pan…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2025-04-16
  Clinical Trial Update: Study of Nab-Paclitaxel and Gemcitabine and Plus/Minus VCN-01 in Patients With Metastatic Pancreatic Cancer [Phase 2]

  Clinical trial update on a Phase 2 study evaluating nab-paclitaxel and gemcitabine with or without VCN-01 in metastatic pancreatic cancer; t…

• CLINICAL_TRIALS trial_result · 2025-04-16
  Clinical Trial Update: Enfortumab Vedotin in Previously Treated Locally Advanced or Metastatic Pancreatic Cancer (EPIC) [Phase 2]

  Phase 2 clinical trial of Enfortumab Vedotin in previously treated locally advanced or metastatic pancreatic cancer (EPIC) is active and not…

• CLINICAL_TRIALS trial_result · 2025-04-10
  Clinical Trial Update: Efficacy and Safety of Dronabinol in the Improvement of Chemotherapy-induced and Tumor-related Symptoms in Advanced Pancreatic Cancer [Phase 3]

  Phase 3 trial evaluating the efficacy and safety of dronabinol for chemotherapy-induced and tumor-related symptoms in patients with advanced…

• CLINICAL_TRIALS trial_result · 2025-04-10
  Clinical Trial Update: Does Recurrent Pancreatic Cancer Really Have Similar Outcome Compared With Primary Metastatic Pancreatic Cancer?

  A Kochi University-sponsored clinical trial evaluating whether recurrent pancreatic cancer has similar outcomes to primary metastatic pancre…

• CLINICAL_TRIALS trial_result · 2025-04-10
  Clinical Trial Update: Evaluating an Alternative Clinical Genetics Cancer Care Deliver Model

  A completed clinical trial from Abramson Cancer Center at Penn Medicine evaluated an alternative genetics-based cancer care delivery model, …

• CLINICAL_TRIALS trial_result · 2025-04-09
  Clinical Trial Update: Application of Celiac Plexus Block in Postoperative Analgesia of Whipple Surgery [Phase 4]

  A Phase 4 clinical trial evaluating celiac plexus block for postoperative analgesia in patients undergoing Whipple surgery has completed.

• CLINICAL_TRIALS trial_result · 2025-04-06
  Clinical Trial Update: Perioperative Immune Function and Clinical Complications in Pancreaduodenectomy

  The trial evaluating perioperative immune function and postoperative complications in patients undergoing pancreaticoduodenectomy for pancre…

• CLINICAL_TRIALS trial_result · 2025-04-06
  Clinical Trial Update: A Multi-center Trial to Evaluate Multiple Regimens in Metastatic Pancreatic Cancer [Phase 3]

  A Phase 3 multi-center trial evaluating multiple regimens for metastatic pancreatic cancer has completed.

• CLINICAL_TRIALS trial_result · 2025-04-06
  Clinical Trial Update: Preventing Viral Pandemic Associated Risk of Cancer Death Using Less Invasive Diagnostic Tests- Liquid Biopsies

  Completed clinical trial update evaluating the use of liquid biopsies to reduce cancer death risk during viral pandemics. The provided snipp…

• CLINICAL_TRIALS trial_result · 2025-04-04
  Clinical Trial Update: Study of XB002 in Subjects With Solid Tumors (JEWEL-101) [Phase 1]

  JEWEL-101 is a Phase 1 trial of XB002 in patients with solid tumors, covering multiple indications. The study has completed.

• CLINICAL_TRIALS trial_result · 2025-04-04
  Clinical Trial Update: The RIOT Trial: Re-Defining Frailty and Improving Outcomes With Prehabilitation for Pancreatic, Liver, or Gastric Cancer [NA]

  The RIOT trial evaluating prehabilitation to reduce frailty and improve outcomes in pancreatic, liver, and gastric cancer has completed.

• CLINICAL_TRIALS trial_result · 2025-04-03
  Clinical Trial Update: Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors [Phase 2]

  A Phase 2 study of seribantumab in adults with NRG1 gene fusion-positive advanced solid tumors has been terminated, with results posted in A…

• CLINICAL_TRIALS trial_result · 2025-04-03
  Clinical Trial Update: RNA Precision Oncology in Advanced Pancreatic Cancer [NA]

  A clinical trial investigating RNA precision oncology in advanced pancreatic cancer has terminated, with results posted.

• CLINICAL_TRIALS trial_result · 2025-04-02
  Clinical Trial Update: A Phase 1/2, Open-label, Multi-center Study of the Safety and Efficacy of Alomfilimab (KY1044) as Single Agent and in Combination With Anti-PD-L1 (Atezolizumab) in Adult Patients With Selected Advanced Malignancies [Phase 1, Phase 2]

  Phase 1/2 open-label study evaluating Alomfilimab (KY1044) alone and with atezolizumab in multiple advanced cancers. The trial was terminate…

• CLINICAL_TRIALS trial_result · 2025-03-30
  Clinical Trial Update: INTER-Regional COHORTE of Long Term Pancreatic Cancer Survivors

  The INTER-Regional COHORTE study of long-term pancreatic cancer survivors has completed.

• CLINICAL_TRIALS trial_result · 2025-03-26
  Clinical Trial Update: BPM31510 Administered Intravenously With Gemcitabine in Advanced Pancreatic Cancer Patients [Phase 2]

  Phase 2 trial evaluating BPM31510 in combination with gemcitabine for advanced pancreatic cancer has completed and results have been posted.

• CLINICAL_TRIALS trial_result · 2025-03-25
  Clinical Trial Update: Ketamine-midazolam as a Sedative Agent in Endoscopic Retrograde Cholangiopancreatography. [Phase 2]

  A Phase 2 trial evaluating a ketamine-midazolam sedative regimen for endoscopic retrograde cholangiopancreatography has completed, involving…

• CLINICAL_TRIALS trial_result · 2025-03-25
  Clinical Trial Update: Tusamitamab Ravtansine Monotherapy and in Combination in Patients With CEACAM5-positive Advanced Solid Tumors [Phase 2]

  Phase 2 study of tusamitamab ravtansine as monotherapy and in combination for CEACAM5-positive advanced solid tumors (metastatic breast canc…

• CLINICAL_TRIALS trial_result · 2025-03-25
  Clinical Trial Update: A Study to Find a Safe and Effective Dose of BI 905711 in Patients With Advanced Gastrointestinal Cancer [Phase 1]

  Phase 1 study to determine a safe and potentially effective dose of BI-905711 in patients with advanced gastrointestinal cancers, including …

• CLINICAL_TRIALS trial_result · 2025-03-25
  Clinical Trial Update: A Trial of Cobicistat and Gemcitabine and Nab-Paclitaxel in Patients with Advanced Stage or Metastatic Pancreatic Ductal Adenocarcinoma [Phase 1]

  Phase 1 trial evaluating cobicistat in combination with gemcitabine and nab-paclitaxel in advanced or metastatic pancreatic ductal adenocarc…